Results 121 to 130 of about 5,788 (178)

Delivering Effective Hepatitis C Virus Treatment in an Embedded Primary Care Setting Within a Tertiary Care Hospital in Karachi, Pakistan. [PDF]

J Viral Hepat
Shah S, Mafirakureva N, Trickey A, Hasnain A, Khan U, Khowaja S, Ashraf H, Baig-Ansari N, Hickman M, Vickerman P, Walker JG, Lim AG.   +11 more
europepmc   +1 more source

Are Direct-Acting Antivirals Effective and Safe for Hepatitis C Patients with Arterial Hypertension? Evidence from a Large Retrospective Real-World Study. [PDF]

Viruses
Brzdęk M, Rzymski P, Zarębska-Michaluk D, Poniedziałek B, Lorenc B, Berak H, Mazur W, Janocha-Litwin J, Tudrujek-Zdunek M, Sitko M, Klapaczyński J, Flisiak R.   +11 more
europepmc   +1 more source

The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]

Korean J Intern Med
Kodsi EM, Ismail H, Issa R, Elshaarawy A, Sakr MA, Shehata EL, Issak ER.   +6 more
europepmc   +1 more source

Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]

Medicine (Baltimore)
Sung BR, Shim SG, Kim KM, Lee JW, Kim JY, Lee BK, Jun CH, Kwan BS.   +7 more
europepmc   +1 more source

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source

High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam. [PDF]

J Viral Hepat
Laureillard D, Binh NT, Vinh VH, Hong TT, Quillet C, Thanh NTT, Vallo R, Quynh BTN, Moles JP, Oanh KTH, Huong DT, Rapoud D, Feelemyer J, Michel L, Vickerman P, Fraser H, Weiss L, Lemoine M, Lacombe K, Jarlais DD, Khue PM, Nagot N.   +21 more
europepmc   +1 more source

HCV RNA detection in hepatic and extrahepatic tissues after DAA-induced sustained virologic response. [PDF]

Biomol Biomed
Mamdouh S, Hamdy H, Aboushousha T, Magdy M, Hammad G, Shemis M, Abdelraouf A.   +6 more
europepmc   +1 more source

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial. [PDF]

Lancet
Cooke GS, Hung LM, Flower B, McCabe L, Hang VTK, Thu VT, Thuan DT, Dung NT, Phuong LT, Khoa DB, An NTC, Thach PN, Huong VTT, Bich DT, Tuyen NK, Ansari MA, Le Ngoc C, Quang VM, Phuong NTN, Thao LT, Tran NB, Kestelyn E, Kingsley C, Van Doorn R, Rahman M, Pett SL, Thwaites GE, Barnes E, Day JN, Chau NVV, Walker AS.   +30 more
europepmc   +1 more source

Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]

JHEP Rep
Wang X, Ha EH, Bian L, Feng Z, Zhang F, O'Shaughnessy K, Wang L, Hochwald A, Zheng Y, Chen W, Zhang Y, Wu X.   +11 more
europepmc   +1 more source

Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]

BMC Infect Dis
Sallam TA, El-Badry RM, Alkully TH, Alfahemi HH, Halwani MA, Alzahrani KI, Alghamdi MA.   +6 more
europepmc   +1 more source